TAMAYO LOUIS EDWARD (Chief Financial Officer) sold 4.6% of their position (4.64K shares) of LEXEO THERAPEUTICS, INC. on the open market
Open‑market sale worth $20.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2026ACC: 0002083206-26-000005
Officer· Chief Financial Officer
Since Feb 2026
+7.36K
Net shares
Net buyer
$20.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
12K acquired · 4.64K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12K
Price / share
—
Trade value
—
% of position
13.4%
6/29/2026
89.67K→101.67K
Common Stock
Direct
Shares
−4.64K
Price / share
$4.49
Trade value
$20.84K
% of position
4.6%
7/1/2026
101.67K→97.02K
Total
Net shares
+7.36K
Net value
-$20.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/29/2026 | A · Award | +12K | — | — | 13.4% | 89.67K | 101.67K |
| Common Stock Direct | 7/1/2026 | S · Sale | −4.64K | $4.49 | $20.84K | 4.6% | 101.67K | 97.02K |
| Total | +7.36K | -$20.84K | ||||||
Derivative Transactions0
No derivative transactions reported